Featured Videos

In this important VIVA24 session, experts examined variations in care across patient populations, combatting biases, and how we can move toward a better future for all patients.

Moderator: Niten Singh, MD

Panel: Joshua Beckman, MD; Donna Buckley, MD; Bryan Fisher, MD; Elina Quiroga, MD, MPH; Vincent L. Rowe, MD; Margaret Tracci, MD, JD

Recorded November 5, 2024.

Award presenter: Niten Singh, MD
ATLAS award recipient: Peter A. Schneider, MD

After accepting the award, Dr. Schneider presents his ATLAS lecture titled Passionate About Vascular Care: "Growing in an Era of Change and Challenge."

This presentation was recorded on October 31, 2023, during the VIVA conference at Wynn Las Vegas.

The VIVA Foundation hosted a special 1-hour webinar providing an exclusive preview of select late-breaking clinical trials ahead of VIVA & The VEINS 2025. Attendees gained early insight into these featured trials:

• JURY-2 Study
• LIFE-BTK Trial
• PROMISE III Trial
• STRIKE-PE Trial
• ROADSTER 3 Study

Originally recorded October 6, 2025.

From 12-month Elegance Registry findings to 24-month SPORTS data, plus a fresh meta-analysis on femoropopliteal stenting. Top experts unpacked the results debuted at LINC & Charing Cross and what they mean for your patients.

Moderator: Sean Lyden, MD

Speakers/Panelists: Marc P. Bonaca, MD, MPH; Andrew Holden, MBChB; D. Christopher Metzger, MD; Leigh Ann O’Banion, MD; Parag J. Patel, MD, MS; Eric Secemsky, MD, MSc

Originally recorded September 3, 2025.

Late-breaking data from the STRIDE and SOUL studies show semaglutide improved symptoms, walking distance, and quality of life for patients with PAD, with SOUL also showing a reduction in adverse limb events. In this 1-hour webinar, the lead authors of both studies joined a panel of multidisciplinary endovascular experts to unpack the implications of these findings, discuss the evolving landscape of medical therapies for PAD, and shared top-line takeaways for clinicians.

Originally broadcast May 21, 2025.

In this clip from VIVA’s recent Data Deep Dive, Dr. Darren McGuire presents new findings from the SOUL study.

Moderator: Joshua Beckman, MD

Panelists: Marc P. Bonaca, MD, MPH; Brian DeRubertis, MD; Daniella Kadian-Dodov, MD; Darren McGuire, MD;

Sahil Parikh, MD; Constantino Peña, MD

Originally broadcast May 21, 2025.

In this clip from VIVA’s recent Data Deep Dive, Dr. Marc Bonaca presents new findings from the STRIDE-PAD study, leading to a spirited conversation on whether all PAD patients should be treated with semaglutide vs real-world limitations and the complexity of treatment decisions.

Watch as leading voices in the vascular field debate the implications of these recent data, and what they could mean for the future of PAD care.

Moderator: Joshua Beckman, MD

Panelists: Marc P. Bonaca, MD, MPH; Brian DeRubertis, MD; Daniella Kadian-Dodov, MD; Darren McGuire, MD; Sahil Parikh, MD; Constantino Peña, MD

Originally broadcast May 21, 2025.

Over the last two years, The VIVA Foundation, the American Venous Forum (AVF), and the American Vein and Lymphatic Society (AVLS) have collaborated to publish a consensus statement on nonthrombotic iliac vein lesions, seeking to address the challenges posed by limited research and to offer clarity to practitioners. A selection of these authors took a closer look at the statements and offered additional insights on the paper’s methodology.

Originally broadcast October 1, 2024.